History

CNServices Ltd was established in 2002 to meet the demand for an experienced and flexible research partner in the field of preclinical drug discovery. The founders of CNServices have extensive research-based expertise in the modelling of central nervous system diseases, and in using sophisticated histological and electrophysiological methods.

Strong background in neuroscience

CNServices combines broad expertise in neuroscience research which is applied to develop new therapeutic treatments for central nervous system diseases. We focus on epileptogenesis, the prevention of damage and restoration of function after experimental stroke, and memory impairment. See Publications for scientific references.

Preclinical contract research organization

CNServices provides research-based services to pharmaceutical and biotechnology companies and research institutes which are in a need of validated and up-to-date testing to speed up the screening process of new compounds. CNServices works in close proximity to clinical practices which can facilitate the entry of potential drugs into Phase I studies.

Collaboration

CNServices has also established collaboration with JSW Lifesciences (Austria) and Imanext Ltd (Finland) offering both preclinical and clinical contract research services.